Trial
NCT05926349
A Study of Andexanet Alfa in Patients Requiring Urgent Surgery or Procedure
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
AstraZeneca
Collaborators
—
Condition
Urgent Surgery
Intervention
Andexanet alfa
Why stopped
Business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-26